XML 22 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net loss $ (2,220) $ (2,127) $ (529)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Net (gain) loss from securities transactions (266) 1,737 (614)
Purchases of securities (2,059) (6,552) (6,523)
Proceeds from sales of securities 7,630 4,281 5,079
Purchases to cover securities sold, not yet purchased (361) (577) (980)
Proceeds from securities sold, not yet purchased 616 952 342
Changes in receivables and payables relating to securities transactions (4,828) 2,085 2,888
Depreciation and amortization 1,034 863 809
Impairment 709 788 135
Loss on extinguishment of debt 5 2 162
Equity earnings from non-consolidated affiliates (64) (62) (50)
Deferred taxes (99) (30) (191)
Other, net 58 4 48
Changes in cash held at consolidated affiliated partnerships and restricted cash 447 168 (1,045)
Accounts receivable, net 72 43 103
Inventories, net (38) (74) 82
Other assets 261 (200) (136)
Accounts payable 18 (32) (21)
Accrued expenses and other liabilities 740 (521) 51
Net cash provided by (used in) operating activities 1,655 748 (390)
Cash flows from investing activities:      
Capital expenditures (826) (1,359) (1,411)
Acquisitions of businesses, net of cash acquired (1,052) (855) (558)
Purchases of investments (100) (345) (78)
Proceeds from sale of investments 67 68 0
Other, net 57 106 90
Net cash used in investing activities (1,854) (2,385) (1,957)
Cash flows from financing activities:      
Investment segment contributions 505 276 500
Investment segment distributions (7) (36) 0
Partnership contributions 1 0 0
Partnership distributions (103) (116) (125)
Proceeds from offering of subsidiary equity 0 31 188
Dividends and distributions to non-controlling interests in subsidiaries (86) (252) (642)
Proceeds from issuance of senior unsecured notes 0 0 4,991
Repayments of senior unsecured notes 0 0 (3,625)
Proceeds from other borrowings 2,199 1,972 4,794
Repayments of borrowings (2,352) (972) (4,031)
Subsidiary repurchase of treasury stock (72) (57) 0
Other, net 2 (20) (42)
Net cash provided by financing activities 87 826 2,008
Effect of exchange rate changes on cash and cash equivalents (31) (7) (10)
Net change in cash of assets held for sale (102) (12) 0
Net decrease in cash and cash equivalents (245) (830) (349)
Cash and cash equivalents, beginning of period 2,078 2,908 3,257
Cash and cash equivalents, end of period 1,833 2,078 2,908
Supplemental information:      
Cash payments for interest, net of amounts capitalized 662 602 607
Net cash payments (refunds) for income taxes 87 (1) 115
Capital expenditures included in accounts payable, accrued expenses and other liabilities 89 88 93
Investment in Pep Boys prior to acquiring a controlling interest 160 0 0
Investment in TER prior to acquiring a controlling interest 126 0 0
LP unit issuance for remaining 25% interest in ARL 35 0 0
Subsidiary common unit issuance for acquisition of CVR Nitrogen 336 0 0
Fair value of investment in Ferrous Resources prior to acquisition of a controlling interest 0 36 0
Icahn Enterprises Holdings      
Cash flows from operating activities:      
Net loss (2,219) (2,126) (528)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Net (gain) loss from securities transactions (266) 1,737 (614)
Purchases of securities (2,059) (6,552) (6,523)
Proceeds from sales of securities 7,630 4,281 5,079
Purchases to cover securities sold, not yet purchased (361) (577) (980)
Proceeds from securities sold, not yet purchased 616 952 342
Changes in receivables and payables relating to securities transactions (4,828) 2,085 2,888
Depreciation and amortization 1,033 862 808
Impairment 709 788 135
Loss on extinguishment of debt 5 2 162
Equity earnings from non-consolidated affiliates (64) (62) (50)
Deferred taxes (99) (30) (191)
Other, net 58 4 48
Changes in cash held at consolidated affiliated partnerships and restricted cash 447 168 (1,045)
Accounts receivable, net 72 43 103
Inventories, net (38) (74) 82
Other assets 261 (200) (136)
Accounts payable 18 (32) (21)
Accrued expenses and other liabilities 740 (521) 51
Net cash provided by (used in) operating activities 1,655 748 (390)
Cash flows from investing activities:      
Capital expenditures (826) (1,359) (1,411)
Acquisitions of businesses, net of cash acquired (1,052) (855) (558)
Purchases of investments (100) (345) (78)
Proceeds from sale of investments 67 68 0
Other, net 57 106 90
Net cash used in investing activities (1,854) (2,385) (1,957)
Cash flows from financing activities:      
Investment segment contributions 505 276 500
Investment segment distributions (7) (36) 0
Partnership contributions 1 0 0
Partnership distributions (103) (116) (125)
Proceeds from offering of subsidiary equity 0 31 188
Dividends and distributions to non-controlling interests in subsidiaries (86) (252) (642)
Proceeds from issuance of senior unsecured notes 0 0 4,991
Repayments of senior unsecured notes 0 0 (3,625)
Proceeds from other borrowings 2,199 1,972 4,794
Repayments of borrowings (2,352) (972) (4,031)
Subsidiary repurchase of treasury stock (72) (57) 0
Other, net 2 (20) (42)
Net cash provided by financing activities 87 826 2,008
Effect of exchange rate changes on cash and cash equivalents (31) (7) (10)
Net change in cash of assets held for sale (102) (12) 0
Net decrease in cash and cash equivalents (245) (830) (349)
Cash and cash equivalents, beginning of period 2,078 2,908 3,257
Cash and cash equivalents, end of period 1,833 2,078 2,908
Supplemental information:      
Cash payments for interest, net of amounts capitalized 662 602 607
Net cash payments (refunds) for income taxes 87 (1) 115
Capital expenditures included in accounts payable, accrued expenses and other liabilities 89 88 93
Investment in Pep Boys prior to acquiring a controlling interest 160 0 0
Investment in TER prior to acquiring a controlling interest 126 0 0
LP unit issuance for remaining 25% interest in ARL 35 0 0
Subsidiary common unit issuance for acquisition of CVR Nitrogen 336 0 0
Fair value of investment in Ferrous Resources prior to acquisition of a controlling interest $ 0 $ 36 $ 0